ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BTG Btg Plc

840.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Btg Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 840.00 839.00 840.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Btg Share Discussion Threads

Showing 6026 to 6047 of 6225 messages
Chat Pages: 249  248  247  246  245  244  243  242  241  240  239  238  Older
DateSubjectAuthorDiscuss
09/12/2018
19:01
It gives me more confidence if Woodford does not think it will happen . :-)
bargainbob
09/12/2018
18:18
The 853p purchase was about 600k shares so not SG.
The other conclusion from the SG/Woodford transaction is that Woodford obviously thinks there will NOT be another bidder.
Given that he is close to Louise Makin, he will have a better appreciation than most I would have thought?

spyder
09/12/2018
17:55
Is there any suggestion they were involved in the 853p purchases? Or were they cancelled?
bscuit
09/12/2018
17:33
Very interesting BB.
So ... Sand Grove bought 16.2m BTG shares from Woodford.
Sand Grove is an ‘event driven’ hedge fund, that is to say, its strategy is to exploit valuation anomalies after a major corporate event such as a bid. Sometimes this will be an equity arbitrage if a perceived mismatch develops between the share price of the buyer and the share price of the seller, but this can’t be the case here as this is an all cash offer.
That being the case, SG have spent approximately £134m to make just £1.5m or a 1.3% return.
This is a tiny profit and does not reflect the risk of the deal failing to complete.
I think we can draw 2 conclusions from this;
1) SG thinks the deal will definitely complete.
2) SG must be betting that another bidder will appear.
Of course, they could be wrong, and their strategy will be to buy multiple bid targets and hope that one or two will receive additional offers.
Their investment in Laing Infrastructure didn’t work, as this sold after just one bid, I wonder if they will have better luck with BTG?

spyder
09/12/2018
14:22
The parts may be greater than the sum .

TIDMBTG

RNS Number : 7475J

Boston Scientific Corporation

07 December 2018

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

7 December 2018

RECOMMENDED CASH OFFER

for

BTG plc

("BTG")

by

Bravo Bidco Limited

("Bravo Bidco")

a newly incorporated entity indirectly wholly-owned by Boston Scientific Corporation ("Boston Scientific")

Update on irrevocable undertaking given by Woodford Investment Management Limited ("Woodford")

On 20 November 2018 the boards of Boston Scientific, Bravo Bidco and BTG announced the terms of a recommended cash offer to be made by Bravo Bidco for the entire issued and to be issued share capital of BTG at a price of 840 pence in cash per BTG Share (the "Rule 2.7 Announcement"). Defined terms in this announcement shall, except where defined in this announcement or the context requires otherwise, have the meanings given to them in the Rule 2.7 Announcement.

Included in the Rule 2.7 Announcement were details of irrevocable undertakings to support the offer including that received from Woodford, which gave an irrevocable undertaking in respect of 21,253,256 BTG Shares (the "Woodford Irrevocable").

On 5 December 2018, Boston Scientific and Bravo Bidco announced that Woodford had sold: (i) 600,000 BTG Shares which were subject to the Woodford Irrevocable to Anavio Capital Partners LLP acting in its capacity as Investment Manager of Anavio Capital Event Driven UCITS Fund; and (ii) 400,000 BTG Shares which were subject to the Woodford Irrevocable to Anavio Capital Master Fund Limited, in each case in accordance with paragraph 2.2(c) of the Woodford Irrevocable.

Woodford has subsequently sold 16,200,000 BTG Shares which were subject to the Woodford Irrevocable (the "Transferred Shares") to Sand Grove Capital Management LLP acting in its capacity as discretionary investment manager on behalf of Sand Grove Opportunities Master Fund Ltd, Sand Grove Tactical Fund LP and Investment Opportunities SPC for the account of Investment Opportunities 2 Segregated Portfolio ("Sand Grove"), in accordance with paragraph 2.2(c) of the Woodford Irrevocable. Therefore, Sand Grove has provided an irrevocable undertaking (the "Sand Grove Irrevocable") on substantially the same terms as the Woodford Irrevocable in respect of the Transferred Shares, save that the provisions in the Woodford Irrevocable permitting transfer of BTG Shares in circumstances, other than to the extent required by law, are not contained in the Sand Grove Irrevocable.

The total number of BTG Shares which is subject to irrevocable undertakings to support the offer remains unchanged.

The Sand Grove Irrevocable (as well as a copy of this announcement) will be uploaded to the Boston Scientific website (hxxp://investors.bostonscientific.com/) shortly.

Enquiries:




Bravo Bidco / Boston Scientific +1 (508) 683-5565
Susie Lisa (Investor Relations)

Barclays Bank PLC, acting through its +44 (0) 20 7623 2323
Investment Bank (financial adviser to
Bravo Bidco and Boston Scientific)
Douglas Solomon
Jed Brody
Derek Shakespeare
Barclays Bank PLC, acting through its investment bank ("Barclays"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively for Boston Scientific and Bravo Bidco and no one else in connection with the matters referred to in this announcement and will not be responsible to anyone other than Boston Scientific and Bravo Bidco for providing the protections afforded to clients of Barclays nor for providing advice in relation to the Acquisition or any other matter referred to in this announcement.

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer, invitation, inducement or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of or exercise rights in respect of any securities, or the solicitation of any vote or approval of an offer to buy securities in any jurisdiction, pursuant to the Acquisition or otherwise nor shall there be any sale, issuance or transfer of any securities pursuant to the Acquisition in any jurisdiction in contravention of any applicable laws.

The Acquisition will be implemented solely pursuant to the terms of the Scheme Document (or in the event that the Acquisition is to be implemented by means of a Takeover Offer, the Offer Document), which will contain the full terms and conditions of the Acquisition, including details of how to vote in respect of the Scheme. Any decision, vote or other response in respect of the Acquisition should be made only on the basis of information contained in the Scheme Document. BTG Shareholders are advised to read the formal documentation in relation to the Acquisition carefully once it has been dispatched.

This announcement does not constitute a prospectus or prospectus-equivalent document.

This announcement has been prepared for the purpose of complying with English law and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom.

In accordance with the Code, normal United Kingdom market practice and Rule 14e-5(b) of the Exchange Act, Barclays and its affiliates will continue to act as an exempt principal trader in BTG securities on the London Stock Exchange. The purchases and activities by exempt principal traders which are required to be made public in the United Kingdom pursuant to the Code will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com. This information will also be publicly disclosed in the US to the extent that such information is made public in the United Kingdom.

Disclosure requirements of the Code

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at hxxp://investors.bostonscientific.com/, by no later than 12 noon (London time) on 10 December 2018. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

OUPUNVRRWBAURUA

(END) Dow Jones Newswires

December 07, 2018 02:00 ET (07:00 GMT)

bargainbob
09/12/2018
11:53
But why bid against each other? Why would BSX not just agree terms with J&J separately?
I think that in order for there to be 2 bidders, they have to want the same parts.

spyder
09/12/2018
10:56
Johnston and Johnston.
bargainbob
09/12/2018
10:42
Who do you think the other rival will be?
Is this conjecture or ... ?

spyder
09/12/2018
10:19
The final drop in the value of the £ on Tuesday , then expect the two rivals to fight it out and take what part of BTG they want .
Boston never wanted all of BTG , sit back and enjoy.

bargainbob
09/12/2018
10:09
What’s in play BB?
BTG?
Brexit?
That message is a bit too cryptic for me!

spyder
08/12/2018
21:11
It's in play guys Tuesday should be interesting .
bargainbob
07/12/2018
09:22
Sloppy Journalism of the Day Award goes to The Times.
The comment in ‘The day’s giggest movers’:
“BTG Dealers buy in ahead of £3.3bn takeover by larger US rival” Change +3.2%
What do you suppose the comment will be tomorrow?
“BTG Dealers sell out ahead of £3.3bn takeover by larger US rival” Change -3.2%?

spyder
06/12/2018
17:26
—> SV - couldn’t agree more!
spyder
06/12/2018
17:21
SV -- too true!
bscuit
06/12/2018
17:19
According to IC Alert someone paid 853p - ie above the price. Suggests possible action?
bscuit
06/12/2018
11:38
Bloody lucky this offer came when it did with this market.
semper vigilans
06/12/2018
09:27
'When' the offer documents are issued, can we then sell our holdings to Boston at the offer price?
fhmktg
05/12/2018
05:08
yes and yes
cannyshoveyergrannyoffthebus
04/12/2018
23:45
Is anything significant happening with all these rns's publishing trading positions?Are they simply making a few pence on each or are some serious positions building in anticipation of a fresh player emerging?
fhmktg
04/12/2018
23:40
Thanks spyder.
fhmktg
04/12/2018
16:52
—> FH
The Offer Document needs to be out by 18 December, unless BTG allows an extension.

spyder
04/12/2018
16:08
Invesco clarifying it's undertaking to put a long stop in for August 2019 to ensure they will be free of commitment if the bidder doesn't complete by that date.All tickety - boo for the offer document to come out.Be nice to see it before the year end, if only to smoke out any other players.
fhmktg
Chat Pages: 249  248  247  246  245  244  243  242  241  240  239  238  Older

Your Recent History

Delayed Upgrade Clock